Search for: "Maryland v. King" Results 301 - 320 of 471
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Mar 2016, 12:56 pm by Jon Sands
Maryland, 373 U.S. 83 (1963), and Napue v. [read post]
18 Mar 2016, 2:37 am by Eugene Volokh
Rev. 731 (2013)); Daniel Lyne and Ted Folkman of Murphy & King were kind enough to serve as our pro bono counsel. [read post]
8 Apr 2016, 3:00 am by SOG Staff
  Ars Technica reports that Maryland law enforcement officers will no longer be deploying stingrays willy-nilly in the Old Line State. [read post]
8 Apr 2016, 3:00 am by SOG Staff
  Ars Technica reports that Maryland law enforcement officers will no longer be deploying stingrays willy-nilly in the Old Line State. [read post]
30 Mar 2009, 1:47 pm
Last week he was charged with credit card fraud, along with two alleged confederates, Erick V. [read post]
3 Mar 2008, 9:32 am
McDonald's Issue: Whether, under the Lanham Act, Burger King met prudential standing requirements to bring a false advertising claim against McDonald's for fraud involved in various promotional games. [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]